Literature DB >> 29277501

The role of angiogenesis, inflammation and estrogen receptors in breast implant capsules development and remodeling.

Francesco Segreto1, Simone Carotti2, Giovanni Francesco Marangi3, Daniele Tosi1, Maria Zingariello2, Alfonso Luca Pendolino1, Laura Sancillo4, Sergio Morini2, Paolo Persichetti1.   

Abstract

BACKGROUND: Capsular contracture is the most common complication following breast implant placement. The multiple factors unbalancing the physiological response to the foreign body have not been fully elucidated. The aim of this study was to investigate the role of neo-angiogenesis, inflammation and estrogen receptors in peri-prosthetic tissue development and remodeling.
METHODS: The study enrolled 31 women who underwent expander substitution with definitive implant. Specimens were stained with hematoxylin/eosin, Masson trichrome, immunohistochemistry and immunofluorescence for alpha-smooth muscle actin, estrogen receptor-α (ER-α), estrogen receptor-β (ER-β), Collagen type I and III, CD31 (as a marker of neo-angiogenesis) and vascular endothelial growth factor (VEGF). Inflammatory infiltration was quantified and analyzed. Transmission electron microscopy was performed for ultrastructural evaluation.
RESULTS: Myofibroblasts, mainly localized in the middle layer of capsular tissue, expressed VEGF, ER-α and ER-β. ER-β expression positively correlated with Collagen type I deposition (p= 0.025). Neo-angiogenesis was predominant in the middle layer. CD31 expression positively correlated with Collagen type I expression (p=0.009) and inflammatory infiltration grade (p= 0.004). The degree of inflammatory infiltration negatively correlated with the time from implantation (p = 0.022). DISCUSSION: The middle layer is key in the development and remodeling of capsular tissue. Myofibroblasts produce VEGF, that induces neo-angiogenesis. New vessels formation is also correlated to the inflammatory response. Collagen deposition is associated with ER-β expression and neo-angiogenesis. These findings may prelude to targeted pharmacologic therapies able to control such interactions, thus hampering the self-sustaining loop promoting the progression of physiologic fibrosis toward pathologic contracture.
Copyright © 2017 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Breast implant capsules; Breast reconstruction; Capsular contracture; Estrogens

Mesh:

Substances:

Year:  2017        PMID: 29277501     DOI: 10.1016/j.bjps.2017.12.003

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  3 in total

1.  The use of acellular porcine dermis, hyaluronic acid and polynucleotides in the treatment of cutaneous ulcers: Single blind randomised clinical trial.

Authors:  Francesco Segreto; Simone Carotti; Giovanni Francesco Marangi; Maria Francesconi; Luca Scaramuzzino; Marco Gratteri; Erika Caldaria; Sergio Morini; Paolo Persichetti
Journal:  Int Wound J       Date:  2020-07-25       Impact factor: 3.315

Review 2.  Engineering Breast Cancer Microenvironments and 3D Bioprinting.

Authors:  Jorge A Belgodere; Connor T King; Jacob B Bursavich; Matthew E Burow; Elizabeth C Martin; Jangwook P Jung
Journal:  Front Bioeng Biotechnol       Date:  2018-05-24

3.  Tamoxifen reduces silicone implant capsule formation in a mouse model.

Authors:  Kevin M Blum; Gabriel J M Mirhaidari; Jacob C Zbinden; Christopher K Breuer; Jenny C Barker
Journal:  FASEB Bioadv       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.